|
Headlines:
|
 |
Back to Pharmacology Articles
Monday 21st February, 2005
|
|
|
A piece of the topical puzzle of how estrogen goes from protecting
women from heart disease to increasing their risk later in life may have been
found.
|
| |
|
|
|
|
|
|
|
|
|
|
|
A piece of the topical puzzle of how estrogen goes from protecting
women from heart disease to apparently increasing their risk later in
life may have been found.
Medical College of Georgia researchers have found changes in blood
vessel chemistry that may explain the dramatic flip-flop in estrogen?s
function that occurs in older women, taking it from a dilator of vessels
to a potentially dangerous constrictor, says Dr. Richard White, MCG
pharmacologist.
Dr. White will present the findings at the American Heart
Association?s Second International Conference on Women, Heart Disease
and Stroke in Orlando, Fla., Feb. 16-19.
He hopes the findings will ultimately make hormone replacement
therapy safer, possibly by adding to the mix compounds that enable
estrogen?s protective role before menopause.
Hormone replacement therapy, touted for its ability to reduce the
risk of heart attack and stroke in postmenopausal women, appears to
increase the risk of those conditions, according to findings of the
Women?s Health Initiative, a 15-year study of more than 161,000 women by
the National Institute of Health?s National Heart, Lung and Blood
Institute.
This bad news about estrogen and the heart puzzled Drs. White and
Scott A. Barman, also an MCG pharmacologist, as much as it did many
physicians who had long prescribed it.
They were studying estrogen?s effects on blood vessels, focusing on
its impact on the smooth muscle cells that allow blood vessels to
contract, thereby regulating blood pressure and blood flow. These
researchers found that estrogen targets nitric oxide synthase 1, one of
three versions of the enzyme that makes the powerful vasodilator, nitric
oxide.
?What we were finding is that estrogen seems to be what you might
call a natural nitroglycerin; nitroglycerin also works by making nitric
oxide,? Dr. White says.
Then they tried to block estrogen?s activity by blocking nitric
oxide. ?What surprised the heck out of me was after we blocked nitric
oxide production and added estrogen, we got a contraction,? says Dr.
White. ?Estrogen now had turned into a constrictor agent, an agent that
would increase blood pressure.?
They looked further and found that normal aging decreases levels of
the cofactors L-arginine and tetrahydrobiopterin ? both critical to
nitric oxide synthase?s production of nitric oxide.
Instead of making nitric oxide, estrogen was producing the powerful
age-promoting ? and apparently vasoconstricting ? oxygen-free radical,
superoxide.
?At first, I thought it was an artifact,? says Dr. White, who
recently received a $1.2 million, four-year grant from the NHLBI to
pursue his findings. But using a porcine heart that is very similar to
the human heart, he and Dr. Barman, along with Dr. David J. Fulton, a
pharmacologist in the MCG Vascular Biology Center, found that every time
they blocked nitric oxide production, estrogen became a vasoconstrictor.
?Under normal conditions, such as a pre-menopausal woman, this
enzyme, nitric oxide synthase, makes nitric oxide,? says Dr. White. ?But
if you block the production of nitric oxide, this nitric oxide synthase
now has a secondary product that normally isn?t made in an appreciable
form. Now it makes a compound called superoxide. It?s an oxidant, and
oxidation is bad in general. It causes a lot of cellular damage. But
what we also have found is that now, instead of causing relaxation, it
causes constriction. So you completely flip-flop the response here.
?One of the things this means is that menopause is a good thing, a
sort of revolutionary endocrinology idea,? says Dr. White. ?Menopause is
adaptive because a woman is not supposed to have as much estrogen when
she gets older because it can kill her.? He holds up a graph plotting
the dramatically dropping rates of tetrahydrobiopterin over a woman?s
life, a drop that parallels the drop in estrogen levels.
?We have to confirm it,? he says of the new grant in which
researchers will use different drugs to mimic aging, drugs that knock
out L-arginine and tetrahydrobiopterin, to try to create an aged artery
and restudy estrogen?s impact.
?Estrogen is so powerful; it affects every system in your body. We
are looking with tunnel vision at its effect on blood pressure control.
What would this do to bone? What would this do to Alzheimer?s? What
happens to the brain is probably very similar,? he says as critical
cofactors drop that enable estrogen to relax blood vessels. ?This could
be a mechanism that would affect practically every system in the body.?
Studies leading to the latest grant also were funded by the NHLBI as
well as the American Heart Association.
Medical College of Georgia.
|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
|
send
to a friend
printer
friendly version
